Deirdre M. B. Hickey

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

Colin H. Macphee, Kitty Moores, Helen Boyd et al. · Biochemical Journal · 1999 · 337 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2

Josie A. Blackie, Jackie C. Bloomer, Murray J. B. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 130 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +6

5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)

Jason Witherington, Vincent Bordas, David Haigh et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 107 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor

Colin H. Macphee, Kitty Moores, Helen Boyd et al. · Biochemical Journal · 1999 · 102 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

The discovery of GSK221149A: A potent and selective oxytocin antagonist

John Liddle, Michael Allen, Alan D. Borthwick et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 92 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8